Loading patent…
AssigneeSungkwang Medical Foundation
InventorsHee Jung An, Yeon Ho Choi, Eun Jin Lim, Yong Wha Moon, Se Wha Kim
Estimating the term…
Provided are a composition for culturing NK cells, and a method of culturing NK cells using the same. According to an aspect, in culturing NK cells from peripheral blood mononuclear cells, when NK cells are cultured in a medium including the composition for culturing NK cells, the composition including IL-15, IL-18, and IL-27, the NK cells may proliferate in large quantities and activation of NK cells may be promoted. Therefore, when the NK cells are used, cancer cell apoptosis or cancer cell-killing ability may be promoted. Accordingly, the NK cells may be used as an effective adoptive immune cell therapy product in cancer prevention or treatment.
A method of culturing natural killer cells (NK cells), the method comprising culturing the NK cells in a composition for culturing NK cells, the composition comprising IL-15 in an amount of 5.0 ng/ml to 20 ng/ml, IL-18 in an amount of 0.25 ng/ml to 2500 ng/ml, IL-27 in an amount of 0.20 ng/ml to 2000 ng/ml, and insulin transferrin selenium (ITS).
Dependencies are inferred from the claim text.